Correlation Between Accustem Sciences and Oxford Cannabinoid
Can any of the company-specific risk be diversified away by investing in both Accustem Sciences and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accustem Sciences and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accustem Sciences and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on Accustem Sciences and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accustem Sciences with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accustem Sciences and Oxford Cannabinoid.
Diversification Opportunities for Accustem Sciences and Oxford Cannabinoid
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Accustem and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Accustem Sciences and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and Accustem Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accustem Sciences are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of Accustem Sciences i.e., Accustem Sciences and Oxford Cannabinoid go up and down completely randomly.
Pair Corralation between Accustem Sciences and Oxford Cannabinoid
Given the investment horizon of 90 days Accustem Sciences is expected to generate 4.59 times less return on investment than Oxford Cannabinoid. But when comparing it to its historical volatility, Accustem Sciences is 4.08 times less risky than Oxford Cannabinoid. It trades about 0.06 of its potential returns per unit of risk. Oxford Cannabinoid Technologies is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 0.51 in Oxford Cannabinoid Technologies on September 24, 2024 and sell it today you would lose (0.23) from holding Oxford Cannabinoid Technologies or give up 45.1% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.4% |
Values | Daily Returns |
Accustem Sciences vs. Oxford Cannabinoid Technologie
Performance |
Timeline |
Accustem Sciences |
Oxford Cannabinoid |
Accustem Sciences and Oxford Cannabinoid Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Accustem Sciences and Oxford Cannabinoid
The main advantage of trading using opposite Accustem Sciences and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accustem Sciences position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.Accustem Sciences vs. Nova Mentis Life | Accustem Sciences vs. PsyBio Therapeutics Corp | Accustem Sciences vs. HAVN Life Sciences | Accustem Sciences vs. TC BioPharm plc |
Oxford Cannabinoid vs. Nova Mentis Life | Oxford Cannabinoid vs. PsyBio Therapeutics Corp | Oxford Cannabinoid vs. HAVN Life Sciences | Oxford Cannabinoid vs. TC BioPharm plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
CEOs Directory Screen CEOs from public companies around the world |